PharmAla Biotech applies for patent on 6 novel MDMA molecules

Mugglehead
By Rowan DunneAug 29, 2022, 9:12 pm190 pts
PharmAla Biotech (CSE: MDMA) has now made more progress on its quest to become an industry leader and promote MDMA therapy. On Monday, the Canadian biotechnology company announced that it filed a Patent Cooperation Treaty (PCT) application for six Novel Chemical Entities (NCEs). Those NCEs include a series of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Damien Cornwell: Leading Through Chaos in New York’s Cannabis Market 68

South Dakota to Crack Down on Hemp Product Sales Starting July 14 49

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.